Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
29 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Yabao Pharmaceutical Group Co., Ltd. (Yabao Pharmaceutical) is a pharmaceutical company that manufactures and markets pharmaceuticals products including western and Chinese medicines, APIs and health care products. The companys products include sennae leaf, senna pods, clove, rhubarb, ivabradine hydrochloride, atorvastatin calciuma, gefitinib, alpha lipoic acid clopidogrel sulfate, tulobuterol hydrochloride, promethazine hydrochlorine, argatroban, nifedipine sustained-release tablets, aminosalicylic acid, l-ornithine-l-aspartate, simvastatin tablets, propranolol hydrochloride, sustained-release tablets, lovastatin tablets and mosapride citrate tablets, among others.

Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have

  
Source:
Document ID
GDPH207648D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Yabao Pharmaceutical Group Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Yabao Pharmaceutical Group Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Yabao Pharmaceutical Group Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Yabao Pharmaceutical Group Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Yabao Pharmaceutical Group Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Yabao Pharmaceutical Group Co., Ltd., Pharmaceuticals &Healthcare, Deal Details1115
  Partnerships111
    Yabao Pharma Enters into Distribution Agreement with LFB Biomedicaments111
    Yabao Pharma Enters into Agreement with Salus Pharma121
    Yabao Pharma Enters into Co-Development Agreement with Sciecure Pharma131
    Yabao Pharma Enters into Co-Development Agreement with Eli Lilly141
    Yabao Pharma Forms Joint Venture with University of South Australia151
    Yabao Pharma to Form Joint Venture with Red Cross Hospital161
    Yabao Pharma Enters into Co-Development Agreement with Eli Lilly for LY2608204171
    Yabao Pharma Enters Into A Development Agreement With Frontage Labs181
  Licensing Agreements191
    Yabao Pharma Enters into Licensing Agreement with Primary Peptides191
    Yabao Pharma Enters into Licensing Agreement with Lawson Health Research Institute201
    Yabao Pharma Enters into Licensing Agreement with MRC Technology211
    Yabao Pharma Enters into Licensing Agreement with Changzhou Le Sun for LS-008221
  Equity Offering231
    Yabao Pharma Plans to Raise USD124 Million in Private Placement of Shares231
    Yabao Pharma Completes First Tranche Of Private Placement Of Common Stock For US$57 Million242
Yabao Pharmaceutical Group Co., Ltd. - Key Competitors261
Key Employees271
Locations And Subsidiaries281
  Head Office281
  Other Locations &Subsidiaries281
Appendix291
  Methodology291
  About GlobalData291
  Contact Us291
  Disclaimer291

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Yabao-Pharmaceutical-Group-Co-Ltd-600351-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-22812>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Yabao-Pharmaceutical-Group-Co-Ltd-600351-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-22812>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research